BeStock  

Prestige Consumer Healthcare PBH

US equityMarket cap rank #2587Drug Manufacturers - Specialty & Generic
$49.63 +$0.03 (+0.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $49.63 0.00%
Open$49.85
Prev close$49.60
Day range$49.43 – $51.23
Volume612.4K
Market cap$2.35B
P/E (TTM)15.3
Dividend yield–

PBH Stock News

Headlines matching Prestige Consumer Healthcare or the PBH ticker, most recent first.

  • CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72Market news · 8 Aug 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH)TipRanks · 6 Aug 2026 · Direct mention
  • William Blair Maintains Prestige Consumer Healthcare(PBH.US) With Buy RatingMarket news · 6 Aug 2026 · Direct mention
  • 8-K: Prestige Consumer Healthcare | 8-K: Current reportSEC · 6 Aug 2026 · Related
  • Prestige Consumer Healthcare | 4: Statement of changes in beneficial ownership of securitiesSEC · 6 Aug 2026 · Related
  • 10-Q: Prestige Consumer Healthcare | 10-Q: Q1 2027 Earnings ReportSEC · 6 Aug 2026 · Related
  • Prestige Consumer Healthcare | 4: Statement of changes in beneficial ownership of securitiesSEC · 6 Aug 2026 · Related
  • Prestige Consumer Healthcare Lifts Outlook After Strong Q1 PositiveTipRanks · 23 Aug 2026 · Related
  • Prestige Consumer Healthcare | 8-K: Current reportSEC · 15 Aug 2026 · Related
  • Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference PositiveGlobeNewswire · 11 Aug 2026 · Related
  • Prestige Consumer Healthcare Inc. (PBH) Clear Eyes and Pillar5 Problems Drive Stock Lower, HBSS InvestigatingPR Newswire · 25 Jun 2026 · Direct mention
  • Research Alert: Pbh Q1: Revenue Up 25% To Cad2.1b On Stampede Deal; Maintains 2026 GuidanceMT Newswires · 7 May 2026 · Direct mention
  • Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $65Market news · 7 May 2026 · Direct mention
  • Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $65 From $77, Maintains Outperform Rating PositiveMT Newswires · 7 May 2026 · Related
  • CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $72 NegativeMarket news · 15 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on PBH.

Sign in to join the discussion.

Scroll to Top